Skip to main content
Log in

The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanoma

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Jiménez-Requena F, Delgado-Bolton RC, Fernández-Pérez C, Gambhir SS, Schwimmer J, Pérez-Vázquez JM, et al. Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma. Eur J Nucl Med Mol Imaging 2010;37:284–300. doi: 10.1007/s00259-009-1224-8.

    Article  PubMed  Google Scholar 

  2. Krug B, Crott R, Lonneux M, Baurain JF, Pirson AS, Vander Borght T. Role of PET in the initial staging of cutaneous malignant melanoma: systematic review. Radiology 2008;249:836–44. doi: 10.1148/radiol.2493080240.

    Article  PubMed  Google Scholar 

  3. Bastiaannet E, Hoekstra OS, Oyen WJ, Jager PL, Wobbes T, Hoekstra HJ. Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases. Ann Surg Oncol 2006;13:919–26. doi:10.1245/ASO.2006.02.007.

    Article  PubMed  Google Scholar 

  4. Brady MS, Akhurst T, Spanknebel K, Hilton S, Gonen M, Patel A, et al. Utility of preoperative [(18)]F fluorodeoxyglucose-positron emission tomography scanning in high-risk melanoma patients. Ann Surg Oncol 2006;13:525–32. doi:10.1245/ASO.2006.02.008.

    Article  PubMed  Google Scholar 

  5. Clark PB, Soo V, Kraas J, Shen P, Levine EA. Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma. Arch Surg 2006;141:284–8. doi:10.1001/archsurg.141.3.284.

    Article  PubMed  Google Scholar 

  6. Horn J, Lock-Andersen J, Sjostrand H, Loft A. Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy. Eur J Nucl Med Mol Imaging 2006;33:887–92. doi: 10.1007/s00259-006-0077-7.

    Article  PubMed  Google Scholar 

  7. Pfannenberg C, Aschoff P, Schanz S, Eschmann SM, Plathow C, Eigentler TK, et al. Prospective comparison of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced malignant melanoma. Eur J Cancer 2007;43:557–64. doi:10.1016/j.ejca.2006.11.014.

    Article  PubMed  Google Scholar 

  8. Reinhardt MJ, Joe AY, Jaeger U, Huber A, Matthies A, Bucerius J, et al. Diagnostic performance of whole body dual modality 18F-FDG PET/CT imaging for N- and M-staging of malignant melanoma: experience with 250 consecutive patients. J Clin Oncol 2006;24:1178–87. doi:10.1200/JCO.2005.03.5634.

    Article  PubMed  Google Scholar 

  9. Romer W, Nomayr A, Greess H, Fiedler E, Platsch G, Schuler-Thurner B, et al. Retrospective interactive rigid fusion of (18)F-FDG-PET and CT. Additional diagnostic information in melanoma patients. Nuklearmedizin 2006;45:88–95. doi: 10.1267/NUKL06020088.

    CAS  PubMed  Google Scholar 

  10. Iagaru A, Quon A, Johnson D, Gambhir SS, McDougall IR. 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma. Mol Imaging Biol 2007;9:50–7.

    Article  CAS  PubMed  Google Scholar 

  11. Whiting P, Rutjes AW, Dinnes J, Reitsma J, Bossuyt PM, Kleijnen J. Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess 2004;8:iii, 1–234.

    Google Scholar 

  12. Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25.

    Article  PubMed  Google Scholar 

  13. Deville WL, Buntinx F, Bouter LM, Montori VM, de Vet HC, van der Windt DA, et al. Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2002;2:9.

    Article  PubMed  Google Scholar 

  14. Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, et al. Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001;19:3635–48.

    CAS  PubMed  Google Scholar 

  15. Knottnerus JA, Muris JW. Assessment of the accuracy of diagnostic tests: the cross-sectional study. J Clin Epidemiol 2003;56:1118–28.

    Article  CAS  PubMed  Google Scholar 

  16. Smidt N, Rutjes AW, van der Windt DA, Ostelo RW, Reitsma JB, Bossuyt PM, et al. Quality of reporting of diagnostic accuracy studies. Radiology 2005;235:347–53.

    Article  PubMed  Google Scholar 

  17. Krug B, Crott R, Roch I, Lonneux M, Beguin C, Baurain JF, et al. Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma. Acta Oncol 2010;49:192–200. doi:10.3109/02841860903440254.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Bruno Krug.

Additional information

An authors reply to this letter is available at http://dx.doi.org/10.1007/s00259-010-1476-3.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krug, B., Pirson, AS., Crott, R. et al. The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanoma. Eur J Nucl Med Mol Imaging 37, 1434–1435 (2010). https://doi.org/10.1007/s00259-010-1475-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-010-1475-4

Keywords

Navigation